Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia

  • PDF / 1,006,875 Bytes
  • 16 Pages / 595.276 x 790.866 pts Page_size
  • 102 Downloads / 228 Views

DOWNLOAD

REPORT

REVIEW ARTICLE

Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia Tim Preijers1   · Lisette M. Schütte2   · Marieke J. H. A. Kruip2 · Marjon H. Cnossen3 · Frank W. G. Leebeek2 · Reinier M. van Hest1 · Ron A. A. Mathôt1,4

© The Author(s) 2020

Abstract Hemophilia A and B are bleeding disorders caused by a deficiency of clotting factor VIII and IX, respectively. Patients with severe hemophilia (

Data Loading...

Recommend Documents
Desmopressin

142 91 165KB

Population Pharmacokinetics and Pharmacodynamics: An Underutilized Resource

171 77 1MB

Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients

156 93 695KB

Hemophilia A

150 103 72MB

Population Pharmacokinetics of Cariprazine and its Major Metabolites

174 12 3MB

Roasting of Nickel Concentrates

243 20 962KB

Quality of Life in Hemophilia

170 35 263KB

Hemophilia B

156 54 3MB

Desmopressin/tranexamic-acid

172 101 166KB

Alteplase/desmopressin/testosterone

154 100 168KB

Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development

168 27 222KB

Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients

195 79 5MB